Back

The reduction of clot lysis time on statins is associated with lipid plaque parameters in optical coherence tomography in acute myocardial infarction

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Insights into pathophysiology of acute coronary syndromes Thrombosis, Platelets, and Coagulation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Konrad Stepien

Jagiellonian University Medical College, John Paul II Hospital, Krakow (Poland)

6 More presentations in this session

Presentation thumbnail
CircPUM1 regulates March5-mediated Pyruvate Kinase M2 (PKM2) ubiquitination to modulate ferroptosis in myocardial ischemia-reperfusion injury
Doctor Q. Li (Qingdao, CN)
Abstract Slides Video
Presentation thumbnail
Characterizing silent plaque ruptures in non-infarct related vessels of patients with AMI: a pooled, multimodality, serial intracoronary imaging study
Doctor R. Kakizaki (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Utility of the right coronary artery perivascular fat attenuation index for diagnosing vasospastic angina
Doctor A. Katasako-Yabumoto (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
De-differentiation of synthetic vascular smooth muscle in human coronary artery plaque fibrous cap to macrophage-like vascular smooth muscle promotes plaque instability
Mr J. Robertson (Bundoora, AU)
Abstract Slides Video
Presentation thumbnail
Retinal ganglion cell dysfunction in patients with coronary microvascular dysfunction
Doctor A. Sakalidis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Insights into pathophysiology of acute coronary syndromes

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Novel pharmacological approaches in acute coronary syndromes
thumbnail
Congress Session
Smaller trials and other studies on atherosclerosis
thumbnail
Congress Session
Plaque characteristics in acute coronary syndromes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources